1. Guidelines for treatment of drug-susceptible tuberculosis and patient care;World Health Organization,2017
2. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis;Clin Infect Dis,2016
3. The Japanese Society for Tuberculosis. Indication of pyrazinamide-including regimen for elderly patients aged 80 or older;Committee of tuberculosis treatment;Kekkaku,2018
4. Anti-tuberculosis drug-induced hepatitis;Wada;Kekkaku,2005
5. Comparison of drug-induced hepatitis occurring in elderly and younger patients during anti-tuberculosis treatment with a regimen including pyrazinamide;Miyazawa;Kekkaku,2013